Pay in 4 interest-free payments of $5.44 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
TB-500 complements these growth factor and receptor-mediated mechanisms through promotion of endothelial progenitor cell (EPC) mobilization and enhancement of vessel maturation processes
Ipamorelin amplifies each pulse Tesamorelin (Egrifta) Mimics natural GHRH to trigger pituitary GH release Clinical Data CJC-1295/Ipamorelin Phase 2 (CJC-1295), preclinical + Phase 2 (Ipamorelin) Tesamorelin (Egrifta) Two Phase 3 RCTs, 816 patients Approved Indication CJC-1295/Ipamorelin None (compounded) Tesamorelin (Egrifta) HIV-associated lipodystrophy Availability CJC-1295/Ipamorelin Compounding pharmacy with prescription Tesamorelin (Egrifta) Compounding pharmacy with prescription (also as branded Egrifta) PeRx Offers Both PeRx prescribes both CJC-1295/Ipamorelin and Tesamorelin
Since its used continuously, glutathione levels can drop due to stress, poor diet, illness or toxin exposure
Performance cycle (10 mg/week for 8 weeks): 80 mg total, requiring 8 vials
US$ 21.26
US$ 29.04
US$ 22.85
US$ 28.29
